LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 63.15 | 17.25 | 8529 | 5061 | 1.6852 | 1.1315 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 65.12 | 17.25 | 1 | 5095 | 0.0002 | -0.2932 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 65.12 | 17.25 | 6622 | 5095 | 1.2997 | 1.0649 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 65.12 | 17.25 | 950 | 5095 | 0.1865 | 0.6298 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 65.12 | 17.25 | 8846 | 5095 | 1.7361 | 1.1391 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 67.09 | 17.25 | 1 | 5221 | 0.0002 | -0.2922 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 67.09 | 17.25 | 6973 | 5221 | 1.3356 | 1.0715 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 67.09 | 17.25 | 656 | 5221 | 0.1257 | 0.5550 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 67.09 | 17.25 | 9160 | 5221 | 1.7545 | 1.1412 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 69.06 | 17.25 | 2 | 5242 | 0.0004 | -0.2299 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 69.06 | 17.25 | 7270 | 5242 | 1.3867 | 1.0809 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 69.06 | 17.25 | 442 | 5242 | 0.0843 | 0.4818 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 69.06 | 17.25 | 9526 | 5242 | 1.8170 | 1.1502 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 71.03 | 17.25 | 1 | 5367 | 0.0002 | -0.2910 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 71.03 | 17.25 | 7543 | 5367 | 1.4054 | 1.0839 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 71.03 | 17.25 | 446 | 5367 | 0.0831 | 0.4810 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 71.03 | 17.25 | 9696 | 5367 | 1.8066 | 1.1481 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 73.00 | 17.25 | 2 | 5546 | 0.0004 | -0.2280 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 73.00 | 17.25 | 7842 | 5546 | 1.4138 | 1.0849 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 73.00 | 17.25 | 372 | 5546 | 0.0671 | 0.4459 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 73.00 | 17.25 | 9980 | 5546 | 1.7992 | 1.1461 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 74.97 | 17.25 | 3 | 5618 | 0.0005 | -0.1891 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 74.97 | 17.25 | 8169 | 5618 | 1.4539 | 1.0917 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 74.97 | 17.25 | 138 | 5618 | 0.0246 | 0.2829 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 74.97 | 17.25 | 10224 | 5618 | 1.8196 | 1.1487 | MN20160310_N02 | N08 |